Medical Issues Associated with Anabolic Steroid Use
This paper critically reviews the 2006 article "Medical Issues Associated with Anabolic Steroid Use: Are They Exaggerated?" by Jay R. Hoffman and Nicholas A. Ratamess. It examines the pharmacological basis of anabolic steroids, their physiological benefits for athletic performance, and the wide range of adverse health effects documented in medical literature — including cardiovascular, hepatic, musculoskeletal, psychological, and reproductive consequences. The review evaluates whether these health risks have been overstated by the medical community, explores differences in effects between men and women, and considers the implications for clinical practice. It concludes with recommendations for physician-athlete collaboration and more rigorous long-term epidemiological research.
- Introduction and Overview: Scope and purpose of the article review
- Critical Evaluation of the Article: Pharmacology, benefits, and systemic risk overview
- Adverse Health Effects by Body System: Cardiovascular, hepatic, bone, and psychological effects
- Effects on Women and Long-Term Unknowns: Sex-specific harms and gaps in long-term research
- Implications for Clinical Practice: Dosage, monitoring, and physician-athlete collaboration
- Conclusion: Non-directive stance and ethical considerations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper maintains a balanced, non-directive tone throughout, neither condemning nor endorsing anabolic steroid use — mirroring the nuanced stance of the source article it reviews.
- It systematically organizes adverse effects by body system (cardiovascular, hepatic, musculoskeletal, psychological), giving readers a clear framework for understanding the breadth of potential harm.
- The review integrates multiple peer-reviewed citations to support or qualify specific claims, strengthening its credibility as a critical evaluation rather than a summary.
- The implications section moves beyond description to offer practical, evidence-informed recommendations for physician-athlete interaction, demonstrating applied analytical thinking.
Key academic technique demonstrated
The paper demonstrates critical article review: it does not merely paraphrase the source but evaluates the strength of evidence, identifies gaps (such as the lack of long-term epidemiological data and the omission of ethical considerations), and draws independent conclusions about clinical implications. This is a core skill in health sciences writing at the undergraduate level.
Structure breakdown
The paper opens with a summary of the reviewed article's scope and argument, followed by a detailed critical evaluation of the pharmacological and physiological claims. It then systematically reviews adverse effects across multiple organ systems, addresses sex-specific differences, and closes with an implications section that reframes the physician's role as collaborative rather than prohibitive. References follow APA style conventions throughout.
Introduction and Overview
This paper is a review of the article "Medical Issues Associated with Anabolic Steroid Use: Are They Exaggerated?" It examines the medical issues related to the use of anabolic steroids by athletes and bodybuilders, who use exogenous sources of testosterone in order to attain attributes that enhance their performance in sports and related activities. These anabolic steroids provide advantages such as increases in lean body mass, heightened aggression, and maturation of male secondary characteristics. They are taken orally or parenterally in a cyclic manner and can be combined with other drugs to increase efficacy.
Although an athlete may gain these advantages, he also faces adverse effects, as these drugs affect multiple body systems including the heart, liver, brain, and bones. It is important to note, however, that there is limited evidence of serious complications, since many of these changes are transient and reversible once the athlete stops using the drugs.
The article neither promotes nor discourages the use of anabolic steroids. It is instead a thorough discussion of different medical problems related to their use and a review of reported cases where adverse effects were observed. The article suggests that physicians should cooperate with athletes and provide sufficient information about controlled use and associated health risks, so that the athlete can make an informed decision about how to weigh those harmful effects.
References
Angel, P., Chester, N., Green, D. et al. (2012). Anabolic steroids and cardiovascular risk. Sports Medicine, 42, 119–134.
Dhar, R., Stout, C.W., Link, M.S. et al. (2005). Cardiovascular toxicities of performance-enhancing substances in sports. Mayo Clinic Proceedings, 80, 1308–1315.
Dickerman, R.D., Pertusi, R.M., Zachariah et al. (1999). Anabolic steroid-induced hepatotoxicity: Is it overstated? Clinical Journal of Sport Medicine, 9, 34–39.
Maravelias, C., Dona, A.M., Stefanidou, C. et al. (2005). Adverse effects of anabolic steroids in athletes: A constant threat. Toxicology Letters, 158, 167–175.
Pavlatos, A.M., Fultz, O., Monberg, M.J. et al. (2001). Review of oxymetholone: A 17α-alkylated anabolic-androgenic steroid. Clinical Therapeutics, 23, 789–801.
Perry, P.J., Lund, B.C., Deninger, M.J. et al. (2005). Anabolic steroid use in weightlifters and bodybuilders: An internet survey of drug utilization. Clinical Journal of Sports Medicine, 15, 326–330.
Simon, R.L. (1984). Fair play: The ethics of sports. Journal of the Philosophy of Sport, 11(1), 6–13. doi:10.1080/00948705.1984.9714408.
Create your account
Always verify citation format against your institution’s current style guide requirements.